---
schema_version: "secwatch.filing_event.v1"
accession: "0000059478-24-000164"
form_type: "8-K"
ticker: "LLY"
cik: "0000059478"
company_name: "ELI LILLY & Co"
filed_at: "2024-07-10T23:59:59+00:00"
generated_at: "2026-05-31T22:18:47.907961+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Eli Lilly CFO Anat Ashkenazi resigns; Gordon Brooks interim CFO from July 15

## Summary
- Anat Ashkenazi resigned as EVP and CFO to pursue opportunity outside pharma; stays through July for transition.
- Gordon Brooks, group VP controller and corporate strategy, named interim CFO effective July 15, 2024.
- Brooks has 29-year Lilly career including CFO of U.S. Bio-Medicines and chief procurement officer.
- No arrangements or family relationships; selection not pursuant to any agreement with outsiders.

## SEC filing metadata
- accession: 0000059478-24-000164
- form_type: 8-K
- ticker: LLY
- cik: 0000059478
- company_name: ELI LILLY & Co
- filed_at: 2024-07-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/0000059478-24-000164-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/lly-20240705.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000059478-24-000164
- JSON: https://secwatch.observer/filing/0000059478-24-000164.json
- Plain text: https://secwatch.observer/filing/0000059478-24-000164.txt

## Key facts
- Executive change
  Gordon Brooks was appointed as interim chief financial officer at ELI LILLY & Co.
  - Action: appointed
  - Role: interim chief financial officer
  source text: Effective July 15, 2024, Gordon Brooks, age 55, group vice president, controller and corporate strategy, of the Company, will assume the role of interim chief financial officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/0000059478-24-000164-index.htm
- Executive change
  Anat Ashkenazi resigned as executive vice president and chief financial officer at ELI LILLY & Co.
  - Action: resigned
  - Role: executive vice president and chief financial officer
  source text: On June 5, 2024, Eli Lilly and Company (the “Company”) announced that Anat Ashkenazi resigned as executive vice president and chief financial officer of the Company to pursue another career opportunity outside of the pharmaceutical industry.
  evidence_url: https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/0000059478-24-000164-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.